These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9922988)

  • 1. Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: a parallel story.
    Passani MB; Blandina P
    Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):725-33. PubMed ID: 9922988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist and antagonist effects of histamine H3 receptor ligands on 5-HT3 receptor-mediated ion currents in NG108-15 cells.
    Allen MC
    Eur J Pharmacol; 1998 Nov; 361(2-3):261-8. PubMed ID: 9865516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB; Esbenshade TA; Pan JB; Radek RJ; Krueger KM; Yao BB; Browman KE; Buckley MJ; Ballard ME; Komater VA; Miner H; Zhang M; Faghih R; Rueter LE; Bitner RS; Drescher KU; Wetter J; Marsh K; Lemaire M; Porsolt RD; Bennani YL; Sullivan JP; Cowart MD; Decker MW; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
    Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue.
    Barnes JM; Barnes NM; Costall B; Naylor RJ; Tyers MB
    Nature; 1989 Apr; 338(6218):762-3. PubMed ID: 2524005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats.
    Blandina P; Giorgetti M; Bartolini L; Cecchi M; Timmerman H; Leurs R; Pepeu G; Giovannini MG
    Br J Pharmacol; 1996 Dec; 119(8):1656-64. PubMed ID: 8982515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.
    Pérez-García C; Morales L; Cano MV; Sancho I; Alguacil LF
    Psychopharmacology (Berl); 1999 Feb; 142(2):215-20. PubMed ID: 10102775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine H3 receptor-mediated impairment of contextual fear conditioning and in-vivo inhibition of cholinergic transmission in the rat basolateral amygdala.
    Passani MB; Cangioli I; Baldi E; Bucherelli C; Mannaioni PF; Blandina P
    Eur J Neurosci; 2001 Nov; 14(9):1522-32. PubMed ID: 11722614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways.
    Blandizzi C; Colucci R; Tognetti M; De Paolis B; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):193-202. PubMed ID: 11219402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine-selective H3 receptor ligands and cognitive functions: an overview.
    Vohora D
    IDrugs; 2004 Jul; 7(7):667-73. PubMed ID: 15243869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of histamine H3 receptors regulating acetylcholine release in rat entorhinal cortex.
    Arrang JM; Drutel G; Schwartz JC
    Br J Pharmacol; 1995 Apr; 114(7):1518-22. PubMed ID: 7606356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of the histamine H3 receptor in the rat hippocampus.
    Alves-Rodrigues A; Timmerman H; Willems E; Lemstra S; Zuiderveld OP; Leurs R
    Brain Res; 1998 Mar; 788(1-2):179-86. PubMed ID: 9555002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of histamine H3 receptor antagonists in two models of spatial learning.
    Komater VA; Buckley MJ; Browman KE; Pan JB; Hancock AA; Decker MW; Fox GB
    Behav Brain Res; 2005 Apr; 159(2):295-300. PubMed ID: 15817192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.
    Esbenshade TA; Fox GB; Cowart MD
    Mol Interv; 2006 Apr; 6(2):77-88, 59. PubMed ID: 16565470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histaminergic neurons modulate acetylcholine release in the ventral striatum: role of H3 histamine receptors.
    Prast H; Tran MH; Fischer H; Kraus M; Lamberti C; Grass K; Philippu A
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):558-64. PubMed ID: 10598795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
    Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
    Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders.
    Esbenshade TA; Browman KE; Bitner RS; Strakhova M; Cowart MD; Brioni JD
    Br J Pharmacol; 2008 Jul; 154(6):1166-81. PubMed ID: 18469850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.